DATA TIMESTAMP
SENDER IDENTIFIER
SUBJECT & CONTENT PREVIEW
TS:
2015-12-09 16:10:39
ID:
hbiden@rosemontseneca.com
SUBJ:
Fwd: The Washington Post short-sells a reporter's integrity - Columbia Journalism Review
RHB
202-333-1880
Begin forwarded message:
> From: Eric Schwerin <eschwerin@rosemontseneca.com>
> Date: December 9, 2015 at 9:50:59 AM EST
> To: Hunter Biden <hbiden@rosemontseneca.com>
> Subject: The Washington Post short-sells a reporter's integrity - Columbia Journalism Review
>
>
>> http://www.
VIEW
TS:
2015-12-09 16:02:11
ID:
jmayer@rosemontseneca.com
SUBJ:
Fwd: NWBO
Hunter-
You are scheduled to talk with Les from NW Bio at 2pm today. Let me know
if that is a problem.
---------- Forwarded message ----------
From: Anna Marie Cotter <acotter@fourmco.com>
Date: Tue, Dec 8, 2015 at 9:42 PM
Subject: NWBO
To: Les Goldman <lgoldman@nwbio.com>
Cc: Joan Mayer <jmayer@ro
VIEW
TS:
2015-12-09 16:00:22
ID:
academicfeedback@sidwell.edu
SUBJ:
Interim notice
Dear Maisy,
You have received an interim dated 12/9/2015 for English 9 with Ms. Scattergood.
Please log-in to Educator<http://www.sidwell.edu/login/pcreducator.aspx?version=V3&type=ParentPortal> to view this report. If you have any questions or concerns, you can be in touch with me, your advisor,
VIEW
TS:
2015-12-09 16:00:22
ID:
academicfeedback@sidwell.edu
SUBJ:
Interim notice
Dear Maisy,
You have received an interim dated 12/9/2015 for Ceramics II with Mr. Prothro.
Please log-in to Educator<http://www.sidwell.edu/login/pcreducator.aspx?version=V3&type=ParentPortal> to view this report. If you have any questions or concerns, you can be in touch with me, your advisor, or
VIEW
TS:
2015-12-09 15:17:23
ID:
jmayer@rosemontseneca.com
SUBJ:
Please call your Uncle Jim
--
*Joan K. Mayer*
Rosemont Seneca Advisors, LLC
1010 Wisconsin Avenue NW, Suite 705
Washington, DC 20007
o: 202-333-1880
m:202-841-8543
jmayer@rosemontseneca.co
VIEW
TS:
2015-12-09 15:17:10
ID:
jmayer@rosemontseneca.com
SUBJ:
Fwd: Resolution, Burisma Geothermal
Is this ok to e-sign?
---------- Forwarded message ----------
From: Vadym Pozharskyi <vadym.pozharskyi@burisma.com>
Date: Wed, Dec 9, 2015 at 10:09 AM
Subject: Resolution, Burisma Geothermal
To: Devon Archer <darcher@rosemontcapital.com>, Sebastian Momtazi <
smomtazi@rosemontcapital.com>, Hunter Bi
VIEW
TS:
2015-12-09 15:09:31
ID:
vadym.pozharskyi@burisma.com
SUBJ:
Resolution, Burisma Geothermal
Colleagues,
Could you please sing another technical resolution on the Burisma
Geothermal.
Sebastian, could you kindly coordinate the signing of the document in turn
by Devon and Hunter.
Best regards,
vady
VIEW
TS:
2015-12-09 15:01:00
ID:
morningscore@politico.com
SUBJ:
=?utf-8?Q?POLITICO's_Morning_Score=2C_presented_by_Sinclair_Broadcast_Grou?=
=?utf-8?Q?p:_GOP_fears_Trump's_ripple_effects_down-ballot_=E2=80=94_Gun_co?=
=?utf-8?Q?ntrol_rises_in_Democratic_primaries_=E2=80=94_DeSantis_super_PAC?=
=?utf-8?Q?_touts_finance_operatives?=
By Elena Schneider | 12/09/2015 09:59 AM EDT
With Scott Bland, Kevin Robillard and Theodoric Meyer
The following newsletter is an abridged version of Campaign Pro's Morning Score. For an earlier morning read on exponentially more races - and for a more comprehensive aggregation of the day's most
VIEW
TS:
2015-12-09 14:50:59
ID:
eschwerin@rosemontseneca.com
SUBJ:
The Washington Post short-sells a reporter's integrity - Columbia Journalism Review
> http://www.cjr.org/the_audit/the_washington_post_shorts-sel.php <http://www.cjr.org/the_audit/the_washington_post_shorts-sel.php>
>
> The Washington Post short-sells a reporter’s integrity
>
> In a piece <http://www.washingtonpost.com/business/northwest-biotherapeutics-stock-woes-highlight-the-har
VIEW
TS:
2015-12-09 14:49:40
ID:
eschwerin@rosemontseneca.com
SUBJ:
Northwest Biotherapeutics to probe allegations of poor governance - The Washington Post
> https://www.washingtonpost.com/business/capitalbusiness/northwest-biotherapeutics-to-probe-allegations-of-poor-governance/2015/12/01/0deaf1ae-97c5-11e5-b499-76cbec161973_story.html <https://www.washingtonpost.com/business/capitalbusiness/northwest-biotherapeutics-to-probe-allegations-of-poor-gover
VIEW